Abstract
Aims To screen for differentially tyrosine-phosphorylated proteins between nasopharyngeal carcinoma (NPC) and normal nasopharyngeal epithelial tissues (NNET) to provide a basis for elucidate the molecular mechanisms of NPC carcinogenesis. Methods Two-dimensional (2-D) electrophoresis was applied to separate proteins from NPC and NNET, respectively, and 2-D Western blotting was performed to detect tyrosine-phosphorylated proteins using antiphosphotyrosine antibody. Differentially tyrosine-phosphorylated proteins were identified by electrospray ionization-quadrupole time-of-flight MS (ESI-Q-TOF MS). NetPhos software was used to predict the tyrosine-phosphorylation sites of the identified proteins, and Western blotting was used to detect the tyrosine-phosphorylated levels of RKIP in NPC and NNET. Results Twenty-five differentially tyrosine-phosphorylated proteins in the two types of tissues were found, 13 of which were identified by ESI-Q-TOF MS. Among the 13 identified proteins, tyrosine-phosphorylated levels of 7 proteins were increased, and those of 6 proteins were decreased in NPC compared with NNET. NetPhos software prediction showed that all the 13 identified proteins contained tyrosine phosphorylation sites, and the differentially tyrosine-phosphorylated level of RKIP in NPC and NNET was confirmed. Conclusion The 13 differentially tyrosine-phosphorylated proteins may be involved in the development and progression of NPC.
Similar content being viewed by others
References
Yu MC. Nasopharyngeal carcinoma: epidemiology and dietary factors. IARC Sci Publ. 1991;105:39–47.
Spano JP, Busson P, Atlan D, et al. Nasopharyngeal carcinomas: an update. Eur J Cancer. 2003;39(15):2121–35. doi:10.1016/S0959-8049(03)00367-8.
Fandi A, Altun M, Azli N, et al. Nasopharyngeal cancer: epidemiology, staging, and treatment. Semin Oncol. 1994;21(3):382–97.
Dua K, Williams TM, Beretta L. Translational control of the proteome: relevance to cancer. Proteomics. 2001;1(10):1191–9. doi:10.1002/1615-9861(200110)1:10<1191::AID-PROT1191>3.0.CO;2-8.
Kovarova H, Hajduch M, Livingstone M, et al. Analysis of state-specific phosphorylation of proteins by two-dimensional gel electrophoresis approach. J Chromatogr B Analyt Technol Biomed Life Sci. 2003;787(1):53–61. doi:10.1016/S1570-0232(02)00729-8.
Soskic V, Gorlach M, Poznanovic S, et al. Functional proteomics analysis of signal transduction pathways of the platelet-derived growth factor beta receptor. Biochemistry. 1999;38(6):1757–64. doi:10.1021/bi982093r.
Hunter T. The Croonian Lecture 1997. The phosphorylation of proteins on tyrosine: its role in cell growth and disease. Philos Trans R Soc Lond B Biol Sci. 1998;353(1368):583–605. doi:10.1098/rstb.1998.0228.
Cheng AL, Huang WG, Chen ZC, et al. Identificating Cathepsin D as a biomarker for differentiation and prognosis of nasopharyngeal carcinoma by laser capture microdissection and proteomic analysis. J Proteome Res. 2008;7(6):2415–26. doi:10.1021/pr7008548.
Xiao ZQ, Chen Y, Yi B, et al. Identification of nasopharyngeal carcinoma antigens that induce humoral immune response by proteomic analysis. Proteomics Clin Appl. 2007;1(7):688–98. doi:10.1002/prca.200600561.
Patarca R. Protein phosphorylation and dephosphorylation in physiologic and oncologic processes. Crit Rev Oncog. 1996;7(5–6):343–432.
Pandey A, Podtelejnikov AV, Blagoev B, et al. Analysis of receptor signaling pathways by mass spectrometry: identification of vav-2 as a substrate of the epidermal and platelet-derived growth factor receptors. Proc Natl Acad Sci U S A. 2000;97(1):179–84. doi:10.1073/pnas.97.1.179.
Gronborg M, Kristiansen TZ, Stensballe A, et al. A mass spectrometry-based proteomic approach for identification of serine/threonine-phosphorylated proteins by enrichment with phospho-specific antibodies: identification of a novel protein, Frigg, as a protein kinase A substrate. Mol Cell Proteomics. 2002;1(7):517–27. doi:10.1074/mcp.M200010-MCP200.
Keller ET, Fu Z, Brennan M. The role of Raf kinase inhibitor protein (RKIP) in health and disease. Biochem Pharmacol. 2004;68(6):1049–53. doi:10.1016/j.bcp.2004.04.024.
Yeung K, Seitz T, Li S, et al. Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature. 1999;401(6749):173–7. doi:10.1038/43686.
Lorenz K, Lohse MJ, Quitterer U. Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2. Nature. 2003;426(6966):574–9. doi:10.1038/nature02158.
Yeung KC, Rose DW, Dhillon AS, et al. Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation. Mol Cell Biol. 2001;21(21):7207–17. doi:10.1128/MCB.21.21.7207-7217.2001.
Granovsky AE, Rosner MR. Raf kinase inhibitory protein: a signal transduction modulator and metastasis suppressor. Cell Res. 2008;18(4):452–7. doi:10.1038/cr.2008.43.
Hendrix MJ, Seftor EA, Chu YW, et al. Coexpression of vimentin and keratins by human melanoma tumor cells: correlation with invasive and metastatic potential. J Natl Cancer Inst. 1992;84(3):165–74. doi:10.1093/jnci/84.3.165.
Ozeki M, Tamae D, Hou DX, et al. Response of cyclin B1 to ionizing radiation: regulation by NF-kappaB and mitochondrial antioxidant enzyme MnSOD. Anticancer Res. 2004;24(5A):2657–63.
Venkataraman S, Jiang X, Weydert C, et al. Manganese superoxide dismutase overexpression inhibits the growth of androgen-independent prostate cancer cells. Oncogene. 2005;24(1):77–89. doi:10.1038/sj.onc.1208145.
Acknowledgments
This study was supported by a grant from National Key Basic Research Program of China (2001CB510207), Outstanding Scholars of New Era from Ministry of Education of China (2002-48), Lotus Scholars Program of Hunan Province, China (2007-362), and key research program from Science and Technology Committee of Hunan, China (04XK1001-1, 05SK1004-1, 06SK2004).
Author information
Authors and Affiliations
Corresponding author
Additional information
Y. Chen and C.-E. Tang contributed equally to this study.
Rights and permissions
About this article
Cite this article
Chen, Y., Tang, CE., Ouyang, GL. et al. Identification of RKIP as a differentially tyrosine-phosphorylated protein in nasopharyngeal carcinoma and normal nasopharyngeal epithelial tissues by phosphoproteomic approach. Med Oncol 26, 463–470 (2009). https://doi.org/10.1007/s12032-008-9147-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12032-008-9147-y